GSK Plc (GSK)
50.46
-0.18
(-0.35%)
USD |
NYSE |
Nov 13, 16:00
50.46
0.00 (0.00%)
After-Hours: 18:00
GSK Market Cap : 101.16B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 101.51B |
| November 11, 2026 | 101.43B |
| November 10, 2026 | 102.69B |
| November 09, 2026 | 103.31B |
| November 06, 2026 | 100.89B |
| November 05, 2026 | 101.05B |
| November 04, 2026 | 102.53B |
| November 03, 2026 | 97.62B |
| November 02, 2026 | 98.48B |
| October 30, 2026 | 99.24B |
| October 29, 2026 | 97.58B |
| October 28, 2026 | 97.70B |
| October 27, 2026 | 102.11B |
| October 26, 2026 | 102.43B |
| October 23, 2026 | 101.73B |
| October 22, 2026 | 103.58B |
| October 21, 2026 | 101.18B |
| October 20, 2026 | 102.41B |
| October 19, 2026 | 100.04B |
| October 16, 2026 | 100.14B |
| October 15, 2026 | 99.15B |
| October 14, 2026 | 96.83B |
| October 13, 2026 | 93.59B |
| October 12, 2026 | 94.90B |
| October 09, 2026 | 94.06B |
| Date | Value |
|---|---|
| October 08, 2026 | 94.14B |
| October 07, 2026 | 95.11B |
| October 06, 2026 | 94.26B |
| October 05, 2026 | 94.16B |
| October 02, 2026 | 95.13B |
| October 01, 2026 | 95.43B |
| September 30, 2026 | 97.43B |
| September 29, 2026 | 99.82B |
| September 28, 2026 | 100.53B |
| September 25, 2026 | 99.60B |
| September 24, 2026 | 100.43B |
| September 23, 2026 | 100.55B |
| September 22, 2026 | 102.59B |
| September 21, 2026 | 103.32B |
| September 18, 2026 | 101.58B |
| September 17, 2026 | 103.28B |
| September 16, 2026 | 101.72B |
| September 15, 2026 | 101.16B |
| September 14, 2026 | 101.24B |
| September 11, 2026 | 97.35B |
| September 10, 2026 | 97.33B |
| September 09, 2026 | 98.36B |
| September 08, 2026 | 98.18B |
| September 04, 2026 | 100.91B |
| September 03, 2026 | 102.89B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 572.23B |
| Johnson & Johnson | 688.44B |
| Eli Lilly & Co. | 1.360T |
| Merck & Co., Inc. | 364.44B |
| Novo Nordisk A/S | 139.36B |
Market Cap Related Metrics
| PE Ratio | 17.59 |
| PS Ratio | 2.286 |
| Price to Book Value | 4.060 |
| Price to Free Cash Flow | 13.10 |
| Price | 50.46 |
| Earnings Yield | 5.68% |
| Operating PE Ratio | 9.240 |
| Normalized PE Ratio | 11.10 |